The global high content screening market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028. More Info:- https://www.imarcgroup.com/high-content-screening-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global High Content
Screening Market Research
and Forecast Report 2023-
2028
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global High Content Screening Market Research Report:
The latest report by IMARC, titled “High Content Screening Market: Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028” " the global high content screening market size
reached US$ 1.2 Billion in 2022.
High content screening (HCS) refers to an advanced approach of cell-based screening in drug discovery
and systems biology that utilizes visualization tools to gather quantitative data from cell populations. It
involves the usage of quantitative data analysis and automated imaging in a high-throughput format.
Also known as high content analysis, it employs multicolor fluorescence imaging to analyze several
biochemical and physical characteristics of the sample cells. As a result, this analytical method of
automated microscopy assists in complex multivariate drug profiling and toxicity studies.
Request Free Sample Report: https://www.imarcgroup.com/high-content-screening-
market/requestsample

4. Report Description
Report Description and Highlights
Global High Content Screening Market Trends:
The global market is majorly driven by the increasing incidences of chronic neurodegenerative diseases, such as
Parkinson’s and Alzheimer’s. This has led to the growing need for affordable and effective drug discovery systems on
the global level, which is providing an impetus to the market growth. HCS is widely preferred by professionals as this
method of microscopy aids in analyzing the potential toxicity of chemicals and complex substances in a resource-
efficient manner. The market is further driven by continual developments in informatics solutions and imaging
instruments.
Moreover, numerous key players are also introducing innovative HCS equipment in the market that are equipped with
software platforms and artificial intelligence (AI) systems in an attempt to improve the visualization capabilities of the
systems. Some of the other factors contributing to the market growth include the growing geriatric population, the
advent of automated systems for analyzing cell separation and scalability, and extensive research and development
(R&D) activities conducted by major players. On account of the aforementioned factors, the market is anticipated to
grow at a CAGR of 8.4% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Product:
• Instruments
• Cell Imaging and Analysis Systems
• Flow Cytometers
• Consumables
• Reagents & Assay Kits
• Microplates
• Other Consumables
• Software
• Services
• Accessories
Breakup by Application:
• Target Identification and Validation
• Primary Screening and Secondary Screening
• Toxicity Studies
• Compound Profiling
• Other Applications

6. Report Description
Report Description and Highlights
Breakup by End-User:
• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutes
• Contract Research Organizations (CROs)
Breakup by Region:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France

7. Report Description
Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

8. Competitive Landscape with Key Players:
• Becton
• Dickinson and Company
• Bio-Rad Laboratories Inc.
• Biotek Instruments Inc.
• Danaher Corporation
• GE Healthcare
• Merck Millipore
• Perkinelmer Inc.
• Tecan Group Ltd.
• Thermo Fisher Scientific
• Yokogawa Electric Corporation
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/high-content-screening-
market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us